Oxford BioSignals poised to add up to 120 jobs: Indiana’s life sciences market, $2.7 million in incentives attract medical startup
How does aviation technology conceived at Oxford University and developed with the help of Rolls-Royce end up being tested at Methodist Hospital and commercialized in Carmel? Oxford BioSignals Medical CEO Frank Cheng knows the answer. Even better, he can explain why his startup is poised to add 120 jobs over the next few years. “At this point, I don’t see anything we can’t do right here in Indiana,” he said. Formed in 2000, Oxford BioSignals began its life when research…